Stockreport

Genmab Portfolio Prioritization Update

Genmab A/S - American Depositary Shares  (GMAB) 
PDF Company Announcement Genmab to discontinue clinical development of acasunlimab following a portfolio reviewDecision reflects prioritization of higher-impact opportuniti [Read more]